QT Imaging to Present at the 3rd Annual B. Riley Securities Oncology Conference

Author's Avatar
Jan 14, 2023

QT Imaging, Inc., a medical imaging company focused on the development and clinical adoption of novel products for breast cancer imaging (“QT Imaging”), today announced participation of John Klock, MD, Chief Executive Officer, in the Third Annual B. Riley Securities Oncology Conference, on January 18th and 19th. The event will feature one-on-one discussions, fireside chats, and presentations regarding cancer treatment, testing, and monitoring modalities with public and private healthcare companies.